SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-24-008873
Filing Date
2024-05-13
Accepted
2024-05-13 13:40:07
Documents
1
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-65565.html 4  
1 PRIMARY DOCUMENT marketforms-65565.xml 4 3956
  Complete submission text file 0001214659-24-008873.txt   5481
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GAMIDA CELL LTD. 116 HUNTINGTON AVENUE BOSTON MA 02116
Business Address
Jenkins Abigail L. (Reporting) CIK: 0001947032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 24938185